6.85
Astria Therapeutics Inc Aktie (ATXS) Neueste Nachrichten
Is Astria Therapeutics Inc. a candidate for recovery playJuly 2025 Big Picture & Smart Investment Allocation Tips - Newser
Does Astria Therapeutics (ATXS) Have the Potential to Rally 333.88% as Wall Street Analysts Expect? - MSN
What earnings revisions data tells us about Astria Therapeutics Inc.2025 Market Overview & Real-Time Volume Analysis Alerts - Newser
Signal strength of Astria Therapeutics Inc. stock in tech scanners2025 Dividend Review & Scalable Portfolio Growth Ideas - Newser
Long term hold vs stop loss in Astria Therapeutics Inc.Portfolio Profit Report & Expert Verified Movement Alerts - Newser
Why Astria Therapeutics Inc. stock attracts strong analyst attention2025 Pullback Review & Reliable Price Action Trade Plans - Newser
Can Astria Therapeutics Inc. hit a new high this monthJuly 2025 Catalysts & Safe Capital Investment Plans - Newser
Q3 EPS Forecast for Astria Therapeutics Raised by Analyst - Defense World
Q3 Earnings Forecast for ATXS Issued By Lifesci Capital - Defense World
Equities Analysts Set Expectations for ATXS Q3 Earnings - Defense World
How high can Astria Therapeutics Inc. stock goMarket Weekly Review & High Conviction Buy Zone Picks - Newser
Price action breakdown for Astria Therapeutics Inc.Weekly Profit Analysis & Consistent Growth Equity Picks - Newser
Can trapped investors hope for a rebound in Astria Therapeutics Inc.Quarterly Performance Summary & Low Risk High Win Rate Stock Picks - Newser
Applying sector rotation models to Astria Therapeutics Inc.Entry Point & Daily Oversold Bounce Ideas - Newser
JMP Securities Increases Astria Therapeutics (NASDAQ:ATXS) Price Target to $26.00 - Defense World
Astria Therapeutics Reports Increased Losses Amid R&D Expansion - TipRanks
Healthcare Stocks Under Analyst Spotlight: Lyra Therapeutics, Stoke Therapeutics, and Astria Therapeutics. - AInvest
Astria Therapeutics price target raised to $26 from $25 at Citizens JMP - MSN
Can Astria Therapeutics Inc. Regain Lost Ground This QuarterWeekly Trend Summary & Accurate Entry and Exit Point Alerts - metal.it
Astria Therapeutics stock price target raised to $26 by JMP on HAE program progress - Investing.com Canada
Shining A Light On Astria Therapeutics As Its Atopic Dermatitis Drug Approaches A Key Milestone - RTTNews
Technical signs of recovery in Astria Therapeutics Inc.July 2025 Review & Entry Point Confirmation Alerts - Newser
Astria Therapeutics Inc. stock momentum explainedMarket Activity Summary & Technical Pattern Based Buy Signals - Newser
Astria Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update - BioSpace
Astria Therapeutics Inc. stock prediction for this weekRisk Adjusted Trade Signal Screening Tool - Newser
Astria Therapeutics ATXS 2025Q2 Earnings Preview Upside Potential on STAR-0215 Phase 3 Advancements - AInvest
what makes astria therapeutics inc. stock price move sharplyFree Sector Rotation Based Trading Opportunities - Newser
Astria Therapeutics, Inc. SEC 10-Q Report - TradingView
Is it time to cut losses on Astria Therapeutics Inc.Pre-Market Stock Movement Summary and Review - Newser
How to build a dashboard for Astria Therapeutics Inc. stockWeekly Market Direction and Sector Summary - Newser
Will Astria Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsFree Market Momentum and Signal Alerts - Newser
How Astria Therapeutics Inc. stock performs during market volatilityFree Momentum Based Equity Trading Plan - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):